Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer - Top-Institutions - MDSpire

Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

By
Camille Yongue
Ammar Asban
Ashley McCormack
Caroline A. Snyder
Isabella Ferraro
Nikolaos Pachos
Michael Zervos
Robert Cerfolio
May 20, 2026
0 min

Frontiers In Surgery

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Lung Cancer Mutation Consortium 3 (LCMC3)

N/A, N/A
Key Differentiators
- Thoracic Surgery
- Oncology
#2

NYU Langone Health

New York, NY
Key Differentiators
- Thoracic Surgery
- Oncology
#3

Ronald Reagan UCLA Medical Center

Los Angeles, CA
Key Differentiators
- Thoracic Surgery
- Oncology
#4

NewYork–Presbyterian/Columbia University Medical Center

New York, NY
Key Differentiators
- Thoracic Surgery
- Oncology
#5

Levine Cancer Institute

Charlotte, NC
Key Differentiators
- Thoracic Surgery
- Oncology

Original Source(s)

Frontiers In Surgery

Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer

by Camille Yongue, Ammar Asban, Ashley McCormack, Caroline A. Snyder, Isabella Ferraro, Nikolaos Pachos, Michael Zervos, Robert Cerfolio
May 20, 2026

Related Content

Frontiers In Immunology

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment

by Chunyu Zhang, Shu Bu, Xiaoyu Wang, Xin Shen, Yang Du, Jiangnan Yang, Zhiwei Miao
May 29, 2026

Frontiers In Oncology

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

by Chengqian Chen, Wei Guo, Xiaoyu Song, Xin Wan, Zhaoxia Li, Haotian Wang, Ou Bai
May 29, 2026

Blood Cancer Journal

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort